Explore the groundbreaking gene therapy age reversal treatment using OSK (Oct4, Sox2, Klf4) CRISPR components that can reverse ageing. This is also a revolutionary scientific breakthrough moving fast from animal studies to human applications. This guide fills knowledge gaps, significantly highlights top expert insights, and presents pivotal studies demonstrating whole-body, continuous reprogramming that reverses age in mice. This post is educational and not medical advice.
UPDATE: Most quotes below are from This Podcast Episode
The Power of OSK: Resetting Your Epigenetic Clock and Reversing Biological Age
OSK comprises three key reprogramming genes, originally identified as Yamanaka factors responsible for embryonic development and peak biological fitness (ages 25-30). Reactivating these genes in adult cells has been shown to reverse cellular ageing dramatically, which also restores youthful gene expression and tissue function In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming (2016).
“We’ve developed human-compatible viral vectors that can deliver OSK both to specific tissues or systemically—effectively resetting organs to a young state.”
— David Sinclair, Harvard Professor and Longevity Pioneer
Sinclair lab research“Only three genes—Oct4, Sox2, and Klf4—are necessary to reset the entire age of an animal. This is a universal mechanism.”
— David Sinclair
Key Studies Demonstrating Whole-Body and Continuous Reprogramming in Mice
Two foundational studies affirm that OSK CRISPR treatments:
- Can be administered generally (whole-body), not just localized, with systemic age reversal effects.
- Work via continuous reprogramming after a one-off treatment, without the need for repeated gene modulation.
- Successfully reverse the biological age of mice, restoring youthful function and gene expression.
Study 1: Partial Reprogramming Ameliorates Aging Signs in Mice
This 2016 NIH study delivered OSK genes systemically and showed sustained reversal of multiple age-related hallmarks in live animals, therefore confirming whole-body impact without tumour formation.
Read the full study here
Study 2: Sustained Vision Recovery by OSK Gene Therapy (2023)
OSK gene therapy with continuous expression was delivered to mice, demonstrating persistent age reversal and vision recovery, highlighting that a single treatment can have long-lasting rejuvenation effects.
Read the study here
Theoretical Steps to Order and Administer OSK CRISPR Treatment
In theory, producing and applying OSK Lipid Nanoparticle CRISPR treatment to reverse ageing involves four straightforward steps:
1. Search and Identify Target Genes in Public Genome Databases
Use online resources like:
- NCBI Gene
- Ensembl Genome Browser
Search for human or canine versions of Oct4 (POU5F1), Sox2, and Klf4.
2. Order CRISPR sgRNA Components from Specialized Manufacturers
Provide the guide RNA sequences for OSK genes to companies such as:
- Integrated DNA Technologies (IDT)
- Synthego
- Thermo Fisher Scientific
- GenScript
These manufacturers synthesize sgRNAs or gene-editing vectors ready for research or therapeutic use.
3. Mix the CRISPR Components into a Lipid Nanoparticle (LNP) Solution
The components are combined with lipid nanoparticles to facilitate delivery into human cells. The mixing process involves dissolving lipids into ethanol and combining with RNA/cargo in acidic buffer using microfluidic mixers or syringes, lastly followed by a quench buffer dilution step to form uniform particles.
Simplified LNP Preparation Process:
- Dissolve lipids (ionizable lipid, cholesterol, phospholipid, PEGylated lipid) in ethanol
- Dissolve sgRNA/mRNA in citrate buffer (pH ~4)
- Rapidly mix ethanol-lipid phase with aqueous RNA buffer in a microfluidic or syringe mixer
- Dilute in quench buffer (PBS/acetate) to fix particle size and dispersity
- Characterize and sterilize final LNP preparation
Detailed protocols and references:
4. Administer the Treatment to Reverse Ageing
The treatment can be administered intranasally—targeting the brain and respiratory tract while also inducing systemic effects—or potentially by injection. Multiple administrations improve efficacy.
Practical Notes and Companies
- OSK is not fully tested, and is currently undergoing much research.
- The approximate cost of materials for a treatment dose is around £3000.
- DIY Groups have reported yielding human successes with intranasal treatments.
- The treatment preparation requires standard biochemical lab equipment, but no highly complex machinery is necessary—just proper mixing and sterile handling.
- Intranasal administration is convenient and minimally invasive, with possible benefits for brain health and longevity.
Expert Quotes Reinforcing the Science
“Well, given that it’s working in dogs and in mice. It’s probably going to work in people, I would imagine. It’s working in monkeys as well.”
— David Sinclair“What we’re doing is mimicking what very young animals do. They turn on reset genes that reprogram the entire organism to a youthful state.”
— David Sinclair“My students don’t think anything of reversing ageing by 70% in an animal or in a cell. It’s commonplace now.”
— David Sinclair
Summary
OSK CRISPR gene therapy is a real and valid age reversal treatment scientifically demonstrated in multiple peer-reviewed studies to work via whole-body delivery and continuous reprogramming after one treatment. By following a clear research and production pipeline, it is theoretically possible to source components, prepare therapeutic lipid nanoparticle delivery systems, and administer safely to induce profound biological rejuvenation.
For more detailed research and ongoing updates, visit the Sinclair Lab.
This article is for educational purposes only and is not medical advice. Consult health professionals before pursuing any treatment.